2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS PatientsNutritional and Metabolic Diseases, TDP-43 proteinopathy, amyotrophic lateral sclerosis, central nervous system disorder, metabolic disease, motor neuron disorder, nervous system disorder, neurodegenerative disease, neuromuscular disease, proteostasis deficiencies, spinal cord disorderRecruitingPhase 32025-09-12NCT03127267
Clinical Trial With Artiflex Presbyopic (Artiplus)Ametropia, eye disorder, hyperopia, myopia, presbyopia, refractive errorActive, not recruitingNot applicable2025-02-20NCT04632784